JNCE - Jounce Therapeutics Inc. (JNCE) CEO Richard Murray On Q4 2021 Results - Earnings Call Transcript
Jounce Therapeutics, Inc. (JNCE) Q4 2021 Earnings Conference Call March 2, 2022 08:00 ET Company Participants Eric Laub - Vice President of Investor Relations Richard Murray - President & Chief Executive Officer Beth Trehu - Chief Medical Officer Kim Drapkin - Chief Financial Officer Dmitri Wiederschain - Chief Scientific Officer Conference Call Participants Ted Tenthoff - Piper Sandler Boris Peaker - Cowen Gavin Scott - JPMorgan Ryan Deschner - Raymond James Colleen Kusy - Baird Nick Abbott - Wells Fargo Zegbeh Jallah - ROTH Capital Partners Swayampakula Ramakanth - H.C. Wainwright Presentation Operator Good morning, ladies and gentlemen and welcome to the Jounce Therapeutics Fourth Quarter and Full Year 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference is being recorded at the company's request. I
For further details see:
Jounce Therapeutics, Inc. (JNCE) CEO Richard Murray On Q4 2021 Results - Earnings Call Transcript